Synthomer plc (SYNT)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 118.00 |
|---|---|
| 52-week range | 16.70 – 123.95 |
| Return, 1 month / 3 months | +6.5% / +40.6% |
| Return, 1 year / 3 years | +104.5% / −33.3% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 120.9% |
| Worst drawdown (1 year) | -72.4% |
| Average daily value traded | 74.99M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Synthomer plc is a specialty chemicals company based in the United Kingdom. It produces water-based polymer emulsions and latex materials, along with other chemical products, which are used in coatings, adhesives, sealants, construction materials, textiles and healthcare applications. Its customers are manufacturers and industrial businesses that use these ingredients in their own products and processes. The company operates through a network of sites in several countries, serving industrial markets across Europe, North America and Asia.
The shares are listed on the London Exchange in UK under the code SYNT, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Synthomer plc (SYNT) trades on the London Exchange in UK. It last closed at GBX 118.00 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 608 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 104.5% and over the last three months it rose 40.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 55.2% | ||
| From 52-week high | -3.3% | ||
| Momentum | 97 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 40.6% | ||
| 6-month return | 142.3% | ||
| 12-month return, skipping the last month | 92.0% | ||
| Stability (higher is calmer) | 5 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 120.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -72.4% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 74.99M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +10.3% |
|---|---|
| 1 month | +6.5% |
| 3 months | +40.6% |
| 6 months | +142.3% |
| 1 year | +104.5% |
| 3 years | −33.3% |
| 5 years | −96.4% |
Signals
| 50-day / 200-day average | 105.46 / 76.02 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.82 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jun 2022 | GBP 0.0785 |
| 7 Oct 2021 | GBP 0.0320 |
| 3 Jun 2021 | GBP 0.0317 |
| 22 Oct 2020 | GBP 0.0111 |
| 3 Oct 2019 | GBP 0.0147 |
| 6 Jun 2019 | GBP 0.0313 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.